Camurus announces approval of Oczyesa® for the treatment of acromegaly in the UK
CAMXLUND, Sweden, Aug. 28, 2025 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Oczyesa®, octreotide subcutaneous depot, marketing authorization for the maintenance treatment in adult patients with...
August 28, 2025Approval
Read more →